Seiichi Mori

AN &XMMEIWCAL _LIGE"LY-DOPED SURCE (US) CELL FOR VIRTUAL GROUND EIGE DENSITY EPROMs

Kuniyoshi Yoshikawa, H. Araki, Seiichi Mori, 1988 .

Irregularities in Candidates Selection of Multi-Aimed University Entrance Examinations

Takahiko Suzuki, Seiichi Mori, Takeshi Michiwaki, 2013, 2013 Second IIAI International Conference on Advanced Applied Informatics.

Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

Ikuo Konishi, Shingo Fujii, Seiichi Mori, 2011, Genome research.

Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer

Tuan Zea Tan, Jean Paul Thiery, Seiichi Mori, 2014, Oncogene.

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Ling-Zhi Wang, Jeffrey T. Chang, Tuan Zea Tan, 2013, EMBO molecular medicine.

Using a stem cell-based signature to guide therapeutic selection in cancer.

Igor Shats, Jeffrey T. Chang, Michael L. Gatza, 2011, Cancer research.

Histotype-specific copy-number alterations in ovarian cancer

Ikuo Konishi, Jean Paul Thiery, Seiichi Mori, 2012, BMC Medical Genomics.

A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription.

Seiichi Mori, Paloma H Giangrande, J. Nevins, 2004, Genes & development.

An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.

Seiichi Mori, J. Nevins, S. Mori, 2008, Cancer cell.